Treatment of proliferative disorders, metastasaes, and drug resi

Details Treatment of proliferative disorders, metastasaes, and drug resi Treatment of proliferative disorders, metastasaes, and drug resi

1994-01-18

1998-12-01

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Heavy metal or compound thereof

514492, A61K 3324, A61K 3128

Patent

active

058434810

ABSTRACT:
The present invention relates to the use of vanadate compounds, or analogues of vanadate compounds, as antiproliferative and anti-metastatic agents, and to compositions containing vanadate compounds adapted for such use in methods for the treatment of proliferative disorders, methods of reducing the ability of a tumor to metastasize and methods for treating drug resistant tumors.

REFERENCES:
patent: 4882171 (1989-11-01), Posner et al.
patent: 5001141 (1991-03-01), Kerr et al.
patent: 5009891 (1991-04-01), Niwa et al.
patent: 5023358 (1991-06-01), Lazaro et al.
patent: 5036096 (1991-07-01), Suto
patent: 5045316 (1991-09-01), Kaplan
patent: 5069913 (1991-12-01), Posner et al.
patent: 5073639 (1991-12-01), Suto
patent: 5175001 (1992-12-01), Lazaro et al.
patent: 5527790 (1996-06-01), McNeill
patent: 5545661 (1996-08-01), Cullinan
patent: 5565491 (1996-10-01), Schieven
patent: 5583242 (1996-12-01), Schieven
Sardar, S.A., et al., Biol. Abstr. 95(10)AB-802, 110965, 1995.
Sakurai, H. 2nd Internat. Meeting on Molecular Mechanisms of Metal Toxicity, Jan. 10-17, 1993.
Dessureault, J. and Weber, J. Cell Biochem. 43:293-296, 1990.
Klarlund, J. et al., Biochim. Biophys. Acta. 971 112-120, 1988.
Keiler, J. et al., Acta Chirurgica Scandinavica-Supplementum, 343:154-64, 1965.
Stern et al., Biochem. Cell. Biol., 71:103, 1993.
William Lau, C.H. et al, Endocrinology, 123:2858, 1988.
Marchisio, P.C. et al., J. Cell. Biol. 37:151, 1988.
Wang and Scott, J. Cell, Physiol. 158:408-416, 1994.
Xuefeng Yin, et al., Molecular and Cellular Biochemistry 115:85-96, 1992.
Conquer, J.A. et al., 39th Annual Meeting, Orthopaedic Research Society, Feb. 15-18, 1993, San Francisco, CA.
Cruz, T. et al., Molecular and Cellular Biochemistry 153:161-166, 1995.
Conquer, J., et al., Annals N.Y. Acad. Sci. Sep. 1994, p. 447.
Wang and Scott, Mol. Cell. Biol. 153:59-67, 1995.
Younes, M. et al., Toxicology 66(1):63-74, 1991.
Sardar, S. et al., Tumor Research 28:51-61, 1993.
Younes, M. et al., Toxicology 7:141-149, 1991.
Sakurai, H. et al., Biochem Biophys Res Commun, 189(2):1090-1095, 1992.
Hanauske, U. et al., Int J Cell Cloning, 5(2):170-178, 1987.
Thompson, H.J. et al., Carcinogenesis, 5(6):849-851, 1984.
Bishayee, A. et al., Acta Physiol. Pharmacol. Bulg, 19/3:83-89, 1993.
A. Petkau, Br. J. Cancer, 55:87-95, 1987.
C. Norman Coleman, Seminars in Oncology 16:169-175, 1989.
Alvarez et al., J. Natl. Cancer Inst. 82(7):589-595, 1990.
Schultz et al., Cancer Res. 48, 5539-5545, 1988.
Wang & Stearns, Cancer Res. 48, 6262-6271, 1988.
Saxena et al., Biochem. Pharmacology 45(3): 539-542, 1993.
Shklar et al., Nutrition and Cancer, 20(2):145-151, 1993.
Kandel et al., Biochim. Biophys. Acta. 1053, 130-134, 1990.
Conquer, Biochim. Biophys. Acta. 1134, 1-6, 1992.
Cruz et al., Biochem. J. 277:327-330, 1991.
Slaga and Bracken, Cancer Research 37:1631-1635, 1977.
Clark, Pathology 18:181-186, 1986.
Schor, Biochem. Pharm. 37(9):1751-1761, 1988.
Fridovich, "Superoxide Dismutase in Biology and Medicine" in Pathology of Oxygen, American Press, Inc., Chapter 1, pp. 1-19, 1982.
Marklund et al., "Oxy-Radicals in the Toxicity of Cellular Toxins" in Oxy Radicals and Their Scavenger Systems, vol. II: Cellular and Medical Aspects, by Elsevier Science Publishing Co., Inc., pp. 96-104, 1983.
Machlin and Bendich, FASEB, 1:441-445, 1987.
Southorn and Powis, Mayo Clin. Proc. 63:381-388, 1988.
McLennan et al., Radiation Research, 84:122-132, 1980.
Scott et al., J. Biol. Chem., 264(5):2498-2501, 1989.
Edsmyr, Pathology of Oxygen, Superoxide Dismutase Efficacy in Ameliorating Side Effects of Radiation Therapy: Double-Blind, Placebo-Controlled Trials in Patients with Bladder and Prostate Tumors, in Chapter 19, pp. 315-326, Academic Press, Inc. 1982.
Thompson et al., Carcinogenesis, vol. 5, No. 6, pp. 849-851, 1984.
Hamada et al., Cancer Research, 48(17), 4926-32, 1988.
Ishikaiva et al., J. Biol. Chem. 268(27), 20116-25, 1993.

Affiliated with

Also associated with

Rating

Treatment of proliferative disorders, metastasaes, and drug resi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of proliferative disorders, metastasaes, and drug resi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of proliferative disorders, metastasaes, and drug resi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2393643